In this interview, Karl Box shows how particle drift analysis with flux techniques enhances oral drug absorption in pharmaceutical research. Can you tell us about Pion’s Rainbow Dynamic Dissolution ...

Congestive heart failure is a disease state distinguished by the regular presence of both renal and hepatic abnormalities in drug handling. One such abnormality involves flaws in the process of drug ...

When you take a time-release drug, you count on it doing what the package says: release the drug slowly into your bloodstream to provide benefits over the specified period of time. When the drug ...

This webinar introduces a dissolution−permeation model that describes particle dissolution within the concentration boundary layer adjacent to a semipermeable surface. Control of particle size is ...

SUSTAINED-release products have been designed to contain in one dosage form the equivalent of several single doses of a drug, which is released to the body over an extended period. This slow release ...

Surface plasmon resonance (SPR) detectors monitor molecular interactions without labels and in real time. SPR imaging (SPRi) has the additional advantage of increased throughput since it monitors ...

As you’re probably aware, the human body, including the GI tract, is mostly water, so if a drug doesn’t dissolve well in water, its absorption into the bloodstream will be incomplete. Lipophilic drugs ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

Over 80% of U.S. drug prescriptions are for generic medicines. 1 Such medicines are an important part of the medical system, helping to alleviate drug shortages and improve access to affordable ...

There exists a unique and clinically relevant time course of urinary drug delivery for a loop diuretic at which the natriuretic response is optimized. This rate of drug delivery resides on the steep ...